InvestorsHub Logo
Followers 57
Posts 5700
Boards Moderated 0
Alias Born 12/13/2004

Re: None

Thursday, 08/08/2019 4:38:43 PM

Thursday, August 08, 2019 4:38:43 PM

Post# of 1194
Here are some highlights of CC. https://www.webcaster4.com/Webcast/ListenPage?companyId=1556&webcastId=31262
1. One or more ex-US partnerships this year. Agenus to keep US rights.
2. Data this year for PD-1 and CTLA4. Will be presented major Conferences.
3. BLA's for these drugs earlier in 2020 than expected.
4. Next gen CTLA4(1181) increasing response rates from 15% to over 60%.
5. 1181 read-out before end of year.
6. 1181 combination with PD-1 trials before end of year.
7. 1223 into clinic.
8. At least two additional IND's before year-end.
9. Shingrix sales over $1.3 billion. Gates funded manufactured source moving ahead.
10. Agentus IND before yearend. Allogenic pan-cancer vaccine.
Etc.,etc...

"The refusal of the real is the number one dogma of our time" Rene Girard

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AGEN News